维普中文期刊产品整合服务

Osteoimmunology: memorandum for rheumatologists

查看全文 作  者:Lidan [1]Zhao;Linfang [2]Huang;Xuan [1]Zhang 高影响力作者 机构地区:[1]Department of Rheumatology & Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory;[2]Department of Rheumatology, the First People's Hospital of Yueyang高影响力机构 出  处:《Science China(Life Sciences)》索引2016年第59卷第12期,共18页高影响力期刊 基  金:supported by the National Natural Science Foundation of China (81550023) 摘  要:Rapid progress has been made in exploring the connections between the skeletal system and the immune system over the past decade. Bone tissue forms developmental niches for hematopoietic stem cells, and activated immune cells are involved in bone metabolism regulation and are potent mediators of osteoporosis and bone erosion under pathological conditions. The interdisciplinary field of osteoimmunology has emerged to pool the knowledge of the interdependence of these two systems, including the shared ligands and receptors, their crosstalk and interaction, and common intracellular signaling pathways with bidirectional influence. The receptor activator of nuclear factor-kappa B(RANK)/RANK ligand(RANKL)/osteoprotegerin(OPG) triad is the key vinculum, with multifaceted potency, being not only essential for osteoclastogenesis but also critical for lymph node organogenesis and lymphopoiesis as well as for immune regulation. In this review, we summarize the progress in this area, focusing on those aspects of interest concerning rheumatic diseases. 关 键 词:OSTEOIMMUNOLOGY bone remodeling OSTEOCLASTOGENESIS immune cells RANKL
相关文献

参考文献(181)

引证文献(3)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费